Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel class of bifunctional anticancer agents discovered at University of Kansas

Nov. 8, 1999

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Nov. 8, 1999

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Nov. 8, 1999

Merck dedicates significant resources to development of nonpeptide GnRH antagonists

Nov. 5, 1999

Magainin to begin additional clinical trials of squalamine

Nov. 5, 1999

Lilly discloses methods of inhibiting multidrug resistance

Nov. 4, 1999

Results from lead-in phase of Xcytrin trial support continued patient enrollment

Nov. 4, 1999

NewBiotics enters agreement with Ilex for colon cancer therapy

Nov. 3, 1999

New cyclin-dependent kinase inhibitors in the Boehringer Ingelheim pipeline

Nov. 3, 1999

Semisynthetic ecteinascidins presented in recent patent issued to U. of Illinois

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...